ELMMB logo
Facebook logo Twitter logo
Menu
MHRA Drug Safety Updates
MHRA Drug Safety Updates

 

MHRA Yellow Card Scheme: please help to reverse the decline in reporting of suspected adverse drug reactions 

Items In This Category

 TitleCreatedDownload
application/pdfMHRA Drug Safety Update April 2022.pdf (262KB)25/04/2022Download
  
application/pdfMHRA Drug Safety Update March-2022-DSU-PDF.pdf (420KB)15/03/2022Download
 Cladribine (Mavenclad): new advice to minimise risk of serious liver injury, Amiodarone (Cordarone X): reminder of risks of treatment and need for patient monitoring and supervision, Metformin in... 
application/pdfDrug Safety Update February -2022-_PDF.pdf (363KB)15/02/2022Download
  
application/pdfDrug Safety Update January -2022-_PDF.pdf (247KB)19/01/2022Download
  
application/pdfDrug Safety Update December 2020-DSU-PDF-1712.pdf (263KB)10/12/2021Download
 Haloperidol (Haldol): reminder of risks when used in elderly patients for the acute treatment of delirium. Venetoclax (Venclyxto▼): updated recommendations on tumour lysis syndrome (TLS).... 
application/pdfDrug Safety Update MHRA November -2021-PDF.pdf (257KB)17/11/2021Download
 Yellow fever vaccine (Stamaril): new pre-vaccination checklist. Adrenaline auto-injectors: reminder for prescribers to support safe and effective use .  
application/pdfDrug Safety Update MHRA October 2021-PDF.pdf (287KB)07/10/2021Download
 Tofacitinib (Xeljanz▼): new measures to minimise risk of major adverse cardiovascular events and malignancies page 2 Chloral hydrate, cloral betaine (Welldorm): restriction of paediatric indication... 
application/pdfDrug safety Update MHRA Sept-2021-DSU-PDF.pdf (208KB)15/09/2021Download
 Topical corticosteroids: information on the risk of topical steroid withdrawal reactions. COVID-19 vaccines and medicines: updates for August 2021.  
application/pdfDrug Safety Update MHRA August -2021-DSU-PDF.pdf (179KB)31/08/2021Download
  
application/pdfDrug Safety Update MHRA July-2021-DSU-PDF.pdf (280KB)08/07/2021Download
 Chloramphenicol eye drops containing borax or boric acid buffers: use in children younger than 2 years . Herbal and homeopathic medicines: reminder to be vigilant for suspected adverse reactions... 
application/pdfDrug Safety Update MHRA June-2021-DSU-PDF.pdf (226KB)17/06/2021Download
 CDK4/6 inhibitors (abemaciclib▼, palbociclib▼, ribociclib▼): reports of interstitial lung disease and pneumonitis, including severe cases. Atezolizumab (Tecentriq▼) and other immune-stimulatory... 
application/pdfDrug Safety Update MHRA May-2021-DSU-PDF.pdf (192KB)19/05/2021Download
 Levothyroxine: new prescribing advice for patients who experience symptoms on switching between different levothyroxine products. COVID-19 vaccines: updates for May 2021.  
Page: [1] [2] [3] [4] [5] [6] [7] [8]
[ Next » ]